International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Global Renal Denervation Systems Market Research Report 2022-2027:
According to the latest report by IMARC Group, titled " RenalDenervationSystemsMarket:GlobalIndustryTrends,Share,Size,Growth,OpportunityandF orecast2022-2027
," the global renal denervation systems market size reached US$ 218.2 Million in 2021.
Renal denervation (RDN) refers to a minimally invasive, catheter-based procedure that is performed to treat resistant hypertension. It involves a radiofrequency ablation, which burns the nerves within the renal arteries. This, in turn, suppresses the nerve activity and modulates the output of the sympathetic nerves, thereby assisting in decreasing the blood pressure.
In addition to this, it lowers renin secretion, improves blood flow, and stimulates natriuresis. Consequently, RDN systems is being widely adopted to treat hypertension coexisting with metabolic abnormalities, sleep apnea, heart failure, chronic kidney disease, and arrhythmias.
Request for a PDF sample of this report: https://www.imarcgroup.com/renal-denervation-systems-market/requestsample
The global RDN systems market is majorly being driven by the growing instances of lifestyle-related disorders, such as therapy-resistant hypertension, due to sedentary lifestyle, evolving dietary habits, and the increasing cigarette smoking population. This is further supported by the rising geriatric population, which is more susceptible to developing such ailments. Moreover, the growingawareness regarding the clinical advantages associated with RDN systems, including quick recovery, cost-effectiveness, and minimal complications are also facilitating the product demand across the globe.
Other than this, continuous investments in research and development (R&D) activities to introduce alternative technologies for RDN, such as micro-infusion, is acting as another growth-inducing factor. Additionally, increasing clinical trials to validate clinical efficiency of RDN over conventional surgeries are creating a positive outlook for the market further.
Lookingforward,themarketisexpectedtogrowataCAGRof40.67%during2022-2027.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/renal-denervation-systems-market
Key Market Segmentation
The research report includes the following segments:
Breakup by Product Type:
• Catheters
o Single Electrode Catheter
o Multi Electrode Catheter
• RF Generator
• Nerve Modifying Agents
Breakup by Product:
• Symplicity
• Vessix (V2)
• EnligHTN
• Paradise
• Iberis
• Others
Breakup by Technology:
• Ultrasound Ablation
• Radiofrequency Ablation
• Microinfusion
Breakup by Application:
• Hypertension
• Cardiac Disorders
• Diabetes
• Renal Failure
• Others
Breakup by End User:
• Diagnostic Centers and Hospitals
• Ambulatory Care Centers
• Others
Breakup by Region:
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
Competitive Landscape with Key Players:
• Boston Scientific Group
• Kona Medical Inc
• Medtronic Plc
• Mercator MedSystems
• ReCor Medical Inc. (Otsuka Holdings Co. Ltd.)
• Renal Dynamics
• St. Jude Medical Inc. (Abbott)
• Terumo Corporation
1. Howhastheglobalrenaldenervationsystemsmarketperformedsofarandhowwillitperform inthecomingyears?
2. Whatarethekeyregionalmarkets?
3. WhathasbeentheimpactofCOVID-19ontheglobalrenaldenervationsystemsmarket?
4. Whatisthebreakupofthemarketbasedontheproducttype?
5. Whatisthebreakupofthemarketbasedontheproduct?
6. Whatisthebreakupofthemarketbasedonthetechnology?
7. Whatisthebreakupofthemarketbasedontheapplication?
8. Whatisthebreakupofthemarketbasedontheenduser?
9. Whatarethevariousstagesinthevaluechainoftheindustry?
10. Whatarethekeydrivingfactorsandchallengesintheindustry?
11. Whatisthestructureoftheglobalrenaldenervationsystemsmarketandwhoarethekey players?
12. Whatisthedegreeofcompetitionintheindustry?
Clickheretovisitthecompletetableofcontentwithlistoffiguresandtables: https://www.imarcgroup.com/renal-denervation-systems-market/toc
We are the trusted business partners to the world's leading corporates, governments, and institutions
We are the trusted business partners to the world's leading corporates, governments, and institutions
© 2022 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
